cemka > Publications > 2020

Classer les publications sur l'année

  • Économie de la santĂ©

    Cost-effectiveness of emicizumab vs bypassing agents in the prevention of bleeding episodes in haemophilia A patients with anti-FVIII inhibitors in France.

    POLACK B, TROSSAËRT M, COUSIN M, BAFFERT S, PRUVOT A, GODARD C.

    Haemophilia ; 2020;27(1)e1-e11

  • BiomĂ©trie et Analyses de bases de donnĂ©es/SNDS

    Cost of Managing Type 2 Diabetes Before and After Initiating Dipeptidyl Peptidase 4 Inhibitor Treatment: A Longitudinal Study Using a French Public Health Insurance Database

    EMERY C, TORRETON E, DEJAGER S, LEVY-BACHELOT L, BINEAU S, DETOURNAY B.

    Diabetes Ther ; 2020;11(2):535-548

  • SantĂ© publique

    Evaluation en éducation thérapeutique.

    SIMON D, DETOURNAY B.

    Education Thérapeutique. Prévention et maladies chroniques Issy les Moulineaux, Elsevier Masson Ed. Collection Abrégés 4Úme édition revue et augmentée ; 2020;407-420

  • SantĂ© publique

    Prise en charge précoce des psychoses émergentes en France. Recensement, description des activités et besoins en 2018.

    LECARDEUR L, MEUNIER-CUSSAC S, GOZLAN G, DUBURCQ A, COUROUVE L, KREBS M-O.

    L’Information psychiatrique ; 2020;96(7),569-576

  • Pharmaco-EpidĂ©miologie

    Mepolizumab in a population with severe osinophilic asthma and corticosteroid dependence: results from French early access programme

    TAILLE C, CHANEZ P, DEVOUASSOUX G, DIDIER A, PISON C, GARCIA G, CHARRIOT J, BOUEE S, GRUBER A, PRIBIL C, BOURDIN A, HUMBERT M.

    Eur Respir J ; 2020;55(6)

  • Pharmaco-EpidĂ©miologie

    Treatment sequence of first and second generation tyrosine kinase inhibitor followed by osimertinib in EGFR-mutated non-small-cell lung cancer: a real life study

    GIRARD N, MORO-SIBILOT D, BOUEE S, EMERY C, TORRETON E, LE LAY K, LUCIANI L, MARITAZ C, CHOUAID C.

    Future Oncol ; 2020;16(16),1115-1124

  • BiomĂ©trie et Analyses de bases de donnĂ©es/SNDS

    Economic burden of coronary artery disease or peripheral artery disease in patients at high risk of ischemic events in the French setting: a claims database analysis.

    EMERY C, TORRETON E, BRIERE JB, THOMAS EVERS T, FAGNANI F.

    J Med Econ ; 2020;23(5):513-520

  • AutresSantĂ© publique

    The management of emergency hospital visits for inflammatorybowel diseases: A French national expert consensus report

    HEBUTERNE X, PEYRIN-BIROULET L, HAUSFATER P.

    Therapie ; 2020;52(4),420-426

  • Autres

    Télésurveillance et expérimentations ETAPES. Quelle pérennité aprÚs 2021 : quel modÚle organisationnel et financement ?

    LE DOUARIN Y, TRAVERSINO Y, GRACIET A, JOSSERAN A, ET LES PARTICIPANTS DE LA TABLE RONDE « SANTE ET ECONOMIE » DES ATELIERS DE GIENS XXXV, BRIAC BILI A, BLAISE L, CHATELLIER G, COULONJOU H, DELVAL C, DETOURNAY B, DURAND ZALESKI I, FOREST J, DAIDANI N, VANDENBERGUE J.

    Therapies ; 2020;75(1),29-42

  • SantĂ© publique

    Exposure of adults to extremely low frequency magnetic field in France: results of the EXPERS study.

    MAGNE I, SOUQUES M, COUROUVE L, DUBURCQ A, REMY E, CABANES PA.

    Radioprotection ; 2020;55(1),39-50